DalsnaFinance › Analyst accuracy › Oppenheimer › CTVA target
Goldman Sachs lowers Corteva stock price target to $20 post-spinoff
Oppenheimer has reduced its price target to $17 from $95, also maintaining an Outperform rating post-spin-off.
A fact about what Oppenheimer published, as reported by Investing.com, not a recommendation from Dalsna Finance; Oppenheimer is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.